FTC eyes resuming insulin lawsuit against drug middlemen
The U.S. Federal Trade Commission's lawsuit against pharmacy benefit managers (PBMs) over insulin pricing practices will ...
Fierce Healthcare10h
FTC Chair Ferguson changes course on recusal from PBM insulin case
Federal Trade Commission Chair Andrew Ferguson has reversed course on his decision to recuse himself from the agency's legal ...
Ferguson Joins, Restarts FTC Case Targeting PBMs Over Insulin Pricing
The FTC's general counsel had stayed the administrative complaint because the two FTC commissioners—Chair Andrew Ferguson and ...
North Alabama pharmacist worries about business future, legislature considers drug dispensing fees
A bill approved by the Alabama Senate sets a $10 drug dispensing fee for pharmacists while also seeking to regulate the ...
FTC looks to revive insulin lawsuit against pharma middlemen
UnitedHealth (UNH) and Cigna (CI) are under pressure as the FTC looks to resume a lawsuit against their PBMs. Read more here.
Devdiscourse13h
Health Sector Faces Turmoil Amidst Insulin Lawsuit Pause and FDA Challenges
The health sector is experiencing significant disruptions, with the FTC halting a lawsuit against pharmacy-benefit managers ...
Crain's New York Business17h
Hudson Valley congressman outlines ‘shocking’ consequences of UnitedHealth acquisitions
Patients encountered billing issues, long wait times and medication disruptions after UnitedHealth went on a physician ...
Investing.com India3h
FTC lawsuit against PBMs for insulin pricing to resume
Investing.com -- The lawsuit filed by the U.S. Federal Trade Commission (FTC) against pharmacy benefit managers (PBMs) over insulin pricing practices is set to resume. The case had been temporarily ...
Westchester - News 129h
Survey of Optum-owned health care practices reveals increasing patient concerns
The results were released this week and found patients are highly critical of the practice’s quality and accessibility of ...